Hui‐Jen Tsai
-
- Pancreatic and Hepatic Oncology Research 8
- Lung Cancer Research Studies 6
- Endocrine and Autonomic Systems top 10%
-
- Neuroendocrine Tumor Research Advances 8
-
- Lymphoma Diagnosis and Treatment 7
-
- Helicobacter pylori-related gastroenterology studies 6
-
- Gastric Cancer Management and Outcomes 5
-
- Neuroblastoma Research and Treatments 5
-
- Gastrointestinal Tumor Research and Treatment 4
- Co-authors
- Jeffrey S. ChangLi‐Tzong ChenSheng‐Fung LinPei‐Yi ChuYi‐Chang LiuHui‐Hua HsiaoYan‐Shen ShanChao-Sung Chang
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Hui‐Jen Tsai
51 papers receiving 574 citations
Peers
Comparison fields: 5 of 71
- Oncology 220
- Endocrine and Autonomic Systems 52
- Aging 10
- Cancer Research 79
- Biochemistry 36
Countries citing papers authored by Hui‐Jen Tsai
This map shows the geographic impact of Hui‐Jen Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Jen Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Jen Tsai more than expected).
Fields of papers citing papers by Hui‐Jen Tsai
This network shows the impact of papers produced by Hui‐Jen Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Jen Tsai. The network helps show where Hui‐Jen Tsai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui‐Jen Tsai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2022 | 13 | |
| 5 | 2022 | 0 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 16 | |
| 8 | 2021 | 14 | |
| 9 | 2021 | 17 | |
| 10 | 2016 | 1 | |
| 11 | 2011 | 6 | |
| 12 | 2011 | 13 | |
| 13 | 2011 | 3 | |
| 14 | 2006 | 9 | |
| 15 | 2006 | 1 | |
| 16 | 2006 | 4 | |
| 17 | 2005 | 2 | |
| 18 | 2004 | 4 | |
| 19 | 2004 | 10 | |
| 20 | 2002 | 17 |
About Hui‐Jen Tsai
Hui‐Jen Tsai is a scholar working on Oncology, Gastroenterology and Hematology, having authored 53 papers that have together received 581 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Neuroendocrine Tumor Research Advances (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Research Studies (6 papers), Helicobacter pylori-related gastroenterology studies (6 papers), Gastric Cancer Management and Outcomes (5 papers), Neuroblastoma Research and Treatments (5 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). The work is most often cited by research in Oncology (220 citations), Endocrine and Autonomic Systems (52 citations) and Aging (10 citations). Hui‐Jen Tsai has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Jeffrey S. Chang, Li‐Tzong Chen, Sheng‐Fung Lin, Pei‐Yi Chu, Yi‐Chang Liu, Hui‐Hua Hsiao, Yan‐Shen Shan, Chao-Sung Chang, Wen‐Chi Yang and Ming‐Yu Yang. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.